AcrySof® IQ PanOptix® Presbyopia Correcting Intraocular Lenses
Important Product Information

The AcrySof® IQ PanOptix® Presbyopia Correcting Intraocular Lens is intended for primary implantation in the capsular bag in the posterior chamber for the visual correction of aphakia secondary to removal of a cataractous lens in adult patients with and without presbyopia, who desire near, intermediate and distance vision with increased spectacle independence.

As with any surgical procedure, there are associated risks. Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens of this type. This is particularly so in a patient with any of the conditions described in the AcrySof® IQ PanOptix® physician labeling. Some patients may experience visual disturbances and/or difficulty seeing due to the multifocal lens design, especially under dim light conditions. As with other multifocal IOLs, visual symptoms may be significant enough that the patient will request explantation of an AcrySof® IQ PanOptix® IOL. Posterior capsule opacification (PCO) may significantly affect the vision of patients with multifocal IOLs sooner in its progression than in patients with monofocal IOLs.

Refer to the Directions for Use labeling for Model TFNT00 for a complete listing of indications, warnings and precautions.